美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
OMONTYS PRESERVATIVE FREE	202799	001	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS PRESERVATIVE FREE	202799	002	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS PRESERVATIVE FREE	202799	003	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS PRESERVATIVE FREE	202799	004	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS PRESERVATIVE FREE	202799	005	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS PRESERVATIVE FREE	202799	006	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS	202799	007	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 10MG BASE/ML (EQ 10MG BASE/ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued
OMONTYS	202799	008	NDA	PEGINESATIDE ACETATE	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	EQ 20MG BASE/2ML (EQ 10MG BASE/ML)	No	No	2012/03/27	2012/03/27	TAKEDA PHARMS USA	Discontinued